Amy Herr
Fortuna: 148 838 $ al 31/05/2026
Fortuna: 148 838 $ al 31/05/2026
Amy E.
Herr is the founder of Zephyrus Biosciences, Inc. (2013).
Dr. Herr is an Independent Director at Bio-Techne Corp.
since 2025.
Formerly, Vice President at Chan Zuckerberg Biohub.
Education includes a doctorate from Stanford University and an undergraduate degree from California Institute of Technology.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 08/05/2026 | 2.880 ( 0 % ) | 148 838 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIO-TECHNE CORPORATION | Director/Miembro de la Junta | 01/01/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
Chan Zuckerberg Biohub
Chan Zuckerberg Biohub Packaged SoftwareTechnology Services Develops technology for medical researcher | Corporate Officer/Principal | - |
Zephyrus Biosciences, Inc.
Zephyrus Biosciences, Inc. BiotechnologyHealth Technology Provides tools for protein analysis at the single cell level | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Bio-Techne Corp.
Bio-Techne Corp. BiotechnologyHealth Technology Manufactures and sells biological products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zephyrus Biosciences, Inc.
Zephyrus Biosciences, Inc. BiotechnologyHealth Technology Provides tools for protein analysis at the single cell level | Health Technology |
Chan Zuckerberg Biohub
Chan Zuckerberg Biohub Packaged SoftwareTechnology Services Develops technology for medical researcher | Technology Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.